In a recent FDA drug safety communication regarding SGLT-2 inhibitor-associated DKA, hypovolemia and acute renal impairment were listed as potential factors that may contribute to the development of a high anion gap metabolic acidosis
If calorie intake remains high, progress may slow or stop despite treatment
So, it must be treated chronically. The researchers noted that they didnt evaluate the effects of intensive behavioral therapy on the maintenance of body weight reduction, which could make a difference in preventing weight regain after coming off the drug
A plan may offer broad diabetes coverage but limited or no obesity-medication benefits
You can also get it from supplements, but most of it is broken down by enzymes in the gut into amino acids, such that only long-term use of large amounts (500 mg or more) appears to modestly raise glutathione levels
For example, just under two in five of current users report drinking less alcohol and dining out less since starting a GLP-1 drug